Hepatitis Clinical Trials

A listing of Hepatitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 100 clinical trials
A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

The purpose of the study is to evaluate on-treatment efficacy against hepatitis D virus (HDV) of JNJ-73763989 + nucleos(t)ide analog (NA) regimen compared to NA alone.

  • 0 views
  • 19 Jul, 2021
  • 71 locations
ADCC Mediated B-Cell dEpletion and BAFF-R Blockade

VAY736 dose testing; VAY736 efficacy and safety testing.

adcc
  • 83 views
  • 25 Jul, 2021
  • 60 locations
  • 0 views
  • 24 Jul, 2021
  • 4 locations
  • 0 views
  • 17 Jul, 2021
  • 58 locations
Treatment of Hemochromatosis

blood tests given to all regular volunteer blood donors. These include screening for the HIV and hepatitis viruses and for syphilis. Patients who meet height and weight requirements may be asked

  • 4 views
  • 28 Jul, 2021
  • 1 location
Tenofovir Alafenamide(TAF) Reduces the Risk of Hepatocellular Carcinoma(HCC) Recurrence

Hepatocellular carcinoma(HCC) is prevalent in the hepatitis B virus(HBV) infection endemic areas. For early stage of HCC, surgical resection, radiofrequency ablation (RFA) or microwave ablation

  • 0 views
  • 19 Jul, 2021
  • 4 locations
The Kentucky Viral Hepatitis Treatment Study

The overarching goal of the Kentucky Viral Hepatitis Treatment Project (KeY Treat) is to increase hepatitis C virus (HCV) treatment access and delivery in a rural Appalachian community, which is

velpatasvir
epclusa
antiviral drugs
sofosbuvir/velpatasvir
opioid
  • 7 views
  • 26 Jul, 2021
  • 1 location
A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Hepatic Impairment

A single oral dose study to investigate the PK and safety of olorofim in mild and moderately hepatically impaired subjects compared to subjects with normal hepatic function.

  • 0 views
  • 30 Jul, 2021
  • 3 locations
A Single-dose Open-label Pharmacokinetic Study of Belapectin (GR-MD-02) in Subjects With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic Impairment

This study will assess the pharmacokinetics of belapectin in subjects with mild, moderate, or severe hepatic impairment according to 3 different Child-Pugh categories: mild, moderate, or severe impairment, compared to matched healthy control subjects.

medication regimen
hepatic ultrasound
electrocardiogram
liver disease
drug tests
  • 0 views
  • 17 Jul, 2021
  • 4 locations
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection

placebo through Week 24 in treatment-naive and treatment-experienced adolescents (aged 12 to < 18 years) with chronic hepatitis B (CHB). Cohort 2 will consist of 2 parts: Part A and Part B

antiviral drugs
tenofovir
hepatitis b antigen
hepatitis
chronic hepatitis
  • 494 views
  • 28 Jul, 2021
  • 103 locations